HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A trial of carbamazepine in borderline personality disorder.

Abstract
Borderline personality disorder does not have a first choice pharmacological treatment. We studied 20 borderline inpatients in a double-blind parallel placebo-controlled trial with carbamazepine for a mean of 30.9 days. No significant positive effects of the drug were found.
AuthorsJ M de la Fuente, F Lotstra
JournalEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology (Eur Neuropsychopharmacol) Vol. 4 Issue 4 Pg. 479-86 (Dec 1994) ISSN: 0924-977X [Print] Netherlands
PMID7894258 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Carbamazepine
Topics
  • Adult
  • Behavior
  • Borderline Personality Disorder (drug therapy, psychology)
  • Carbamazepine (therapeutic use)
  • Cross-Over Studies
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Psychiatric Status Rating Scales

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: